Simone Jacoby is a Senior Clinical Project Coordinator in the Therapeutic Vaccine Research Program. Her research interests have focussed on HIV, working on many studies evaluating the safety and efficacy of various antiretroviral regimens and looking at IL-2 in the treatment of HIV. Her work has contributed to the change of international HIV treatment guidelines following the results of the START study.
Currently Simone is responsible for the implementation and coordination of the D²EFT study.
BSc, DipNutrition, AdvDip Bot Med
D²EFT study: a large, multi-centre, international clinical trial evaluating the safety and efficacy of dolutegravir + darunavir/r versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first line therapy in predominantly low-middle income countries.
The Kirby Institute for infection and immunity in society was formerly known as the National Centre in HIV Epidemiology and Clinical Research
The Kirby Institute
Wallace Wurth Building
Sydney NSW 2052
T +61 (2) 9385 0900F +61 (2) 9385 0920E firstname.lastname@example.org
Copyright © 2012 UNSW MEDICINE - Kirby Institute - CRICOS Provider Code: 0098G - ABN 57 195 873 179
Authorised by The Kirby Institute - Page Last Updated:
17:23:50 PM, Tuesday 28 March 2017